Physician profile
Erin E Williams
NPI 1366822546
$1,825.88
in general payments reported to CMS, 2019-2025
19 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $402 · 2022: $211 · 2023: $501 · 2024: $266 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $349.33 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $294.81 | 2021-2025 | Repatha, Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $232.85 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $188.05 | 2021-2025 | |
| Glaxosmithkline, LLC. | $146.15 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2023 | Rexulti |
| Lilly USA, LLC | $83.12 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $73.77 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $47.83 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.94 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $40.97 | 2023-2025 | Gvoke Hypopen |
| Amarin Pharma, INC. | $37.76 | 2021 | |
| Sonex Health, INC. | $37.60 | 2025 | Sx-One Microknife |
| Pfizer INC. | $36.71 | 2021 | |
| Alkermes, INC. | $20.88 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.67 | 2025 | |
| Esperion Therapeutics, INC. | $17.51 | 2021 | |
| Abbott Laboratories | $14.53 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.